3-Methyl-l-oxa-bicyclo (4,l,0)hept-5-en-2-one-4,6-dicarboxylic Acid Dimethylester, 3-Methyl-2H-pyran-2-one-4,6-dicarboxylic Acid
Introduction
The phenomenon of dormancy is found in the seeds of many plants. There can by many reasons for dormancy [1] . O f special interest are germination in hibitors, i.e. compounds which inhibit germination at higher concentrations and partially inhibit root and shoot growth at lower concentrations. Inhibition of this type of compounds is reversible, i.e. germina tion, root and shoot growth is normal after removal of the compound.
A quantitative bioassay for germination inhibitors was developed by us [2] using seeds of Amaranthus caudatus; percentage of germination and length of radicle were used for quantitation. With this assay, several germination inhibitors were isolated, inter alia tt-pentane-l,3,4-tricarboxylic acid (VII, dihydrohematimic acid) from Avena sativa [3] .
In the course of investigation of the highly dor mant seeds of Rosa canina, we isolated a new apyrone which acts very efficiently as germination in hibitor. Although the compound turned out to be an artificial product of the isolation procedure it de-serves interest because its structure bears some re semblance to dihydrohematinic acid. The isolation, structural elucidation and some properties of the new compound and of the parent natural product are de scribed here.
Materials and Methods

Isolation of the a-pyrones I and I I
Mature fruits of Rosa canina were collected near Munich during August and September. The plant material was either extracted immediately or stored at -18 °C until use. Compounds with inhibitor activ ity were only detected in the seeds but not in the pulp. For large scale preparations, it was preferred to extract broken fruits and remove more contaminats by subsequent chromatographic methods rather than to mechanically separate seeds from the pulp at first. 500 g of frozen fruits (corresponding to 38 g seeds) were briefly ground (5s) in a Waring blendor to re lease the seeds. The whole mixture was then extracted with boiling water [21] for 48 h in a Soxhlet extrac tor. The aqueous solution (about 1.8 1) was adjusted to pH 8 with N a H C 0 3 and repeatedly extracted with diethylether. The ether phase which mainly con tained neutral compounds without much bioactivity was discarded. The aqueous phase was then acidified to pH 1 with H 2S 0 4 and exhaustively extracted with diethylether in a perforator. The aqueous phase which did not show any more bioactivity was dis carded. The ether phase which contained acidic com pounds was dried with Na2S 0 4 and evaporated to dryness in vacuo.
The residue of the acid fraction was dissolved in 3 ml methanol and applied to a Sephadex LH-20 column (600 x 50 mm) which then was eluted with water at a flow rate of 90 ml/h. Fractions of 8 ml each were collected. The largest inhibitory zone was found in fractions 15-40. The combined fractions were lyophilized and the residue was methylated with diazomethane. For the preparation of deuterium-labelled compounds, deuterodiazomethane was used. As soon as the nitrogen forma tion had stopped, the excess of diazomethane was removed under reduced pressure. The main com pound, citric acid trimethylester, crystallized from a small volume of diethylether and was removed by filtration. The supernatant was evaporated and the residue distilled at 0.5 torr. The compound investi gated here was found in the fraction boiling between 100 °C and 150 °C.
Further purification was achieved by chromatogra phy on silicia gel (Li-Chropep Si 60, Fa. Merck, Darmstadt) with hexane containing increasing amounts of ethyl acetate (5 -100%). Fractions with the highest bioactivity which eluted at a concentra tion of 45-55% ethyl acetate were combined. These fractions contained according to GC-MS analysis (see below) only the a-pyrones I and II. By fraction ated crystallization from hexane/ethylacetate (70:30, v:v), both compounds were obtained in pure form. The pyrone I crystallized at first from the mixture; the crystals were washed with ice-cold diethylether and recrystallized from hexane/ethylacetate. Purity of I was controlled by GC. The mother liquid was reduced in its volume. After crystallisation of mix tures of I and II, finally pure II was obtained. The crystals were also washed with a small volume of icecold diethylether and recrystallized from hexaneethylacetate.
GC-MS
GC-MS analyses were performed on a Varian MAT 312 mass spectrometer with a combined EI/CI ion source connected to a Varian gaschromatograph model 3700. The mass spectrometer was operated under the following conditions: electron energy: 70V; ion source: 220 °C; scan: 34.5-400 m/z. High resolution data were obtained by peak matching in combination with a MAT SS 200 data system. The gas chromatograph was operated with a glas capillary column filled with OV1. The carrier gas was helium with a flow rate of 2 ml min-1. The injector and de tector temperature was 275 °C. The temperature of the column was programmed from 50 °C to 250 °C at 3 °C min-1.
NMR-spectrometry
'H-NMR spectra were obtained with a Bruker in strument model WP 80 FT and an Aspect 2000 data system. Spectra were run at 35 °C. 13C-NMR spectra were recorded on a W M 400 Spectrometer, Fa. Bruker.
Bioassay
The test for inhibitory activity was performed as previously described [2] with seeds of Amaranthus caudatus. Seeds (from Bayerische Futtersaatbau G m bH , Ismaning, FRG ) were germinated at 27 ± 1 °C. Percentage of germination and radicle length were determined after 48 h.
Synthesis of reference compounds
Dimethyl-6-methyl-2H-pyran-2-one-3.5-dicarboxylate (III) was prepared by condensation of methyl methoxymethylenecyanoacetate and methylacetoacetate according to Simonsen [4] . The methylmethoxymethylenecyanoacetate required was ob tained by the method described by Bollemont [5] . 'H-NMR: 6 = 2.6 ppm (3 H); 3.45 (2 H); 3.7 (3 H); 3.85 (3 H); 7.7 ppm (1 H).
Methyl-4.6-dimethyl-2H-pyran-2-one-5-carboxylate (isodehydracetic acid methylester) (V) was ob tained from E G A . 
Results and Discussion
Identification of compound I
Both compounds present in the fractions with biological activity proved to be closely related apyrone derivatives. At first compound I was identified as dimethyl-3-methyl-2-H-pyran-2-one-4.6-dicarboxylate.
The molecular weight of I is 226, its molecular formular C 10H 10O 6 was determined by high resolu tion mass spectrometry.
Major fragment ions were observed at m/z 194 (M +-C H 3O H ), m/z 167 (M +-C H 3C O O ; basepeak) and m/z 139 (m/z 167 -CO). Besides these frag mentations for carboxylic acid esters the primary loss of m/z 28 (CO) from the molecular ion indicated the presence of a lactone structure. The expulsion of carbon monoxide from a given molecular ion yield ing a furan derivative is typical for a-pyrones [6] . The loss of CO was found with all reference compounds (see Material and Methods).
The 'H-NMR and 13C-NMR data of I are given in Table I .
The 'H-NMR spectrum of I presented one singulet (6 H) at 6 = 4.0 ppm for two methylester groups and one singulet at 6 = 2.5 ppm characteristic of a methyl group in a-position to a carboxylic group. The signal at 6 = 7.45 ppm belongs to one isolated proton at tached to a double bond. The 13N M R spectrum of 1 was more informative. The signal at 6 = 161.5 ppm for the carbon in position 2 established the 2 H-pyran-2-one structure. In the coupled spectrum this sig nal gave a quartet with the long range C,H-coupling of 4 Hz due to the coupling with the methylenic group that therefore must be located at position 3. The C 5 showed a doublet centred at Ö = 109.8 ppm with the 'J C,H coupling constant of 178 Hz, due to the coupling with the isolated proton at position 5. The two carboxylic acid ester groups must be positioned at the remaining positions 4 and 6 ; the signal of the second group is downfield-shifted be cause of the neighbouring oxygen carbon atom.
Identification o f the inhibitor II
H La 4b C00CH3 Mass spectrometric data and the 'H and 13C N M R data of the inhibitor II indicated close structural resemblence with the 2-H-pyran-2-one derivate I. The mass spectrum of the inhibitor as well as the spec trum of the deuteriumlabeled compound is presented in Fig. 1 .
The high resolution data confirmed that the molecular ion m/z 240 corresponds to C n H 120 6; this suggests that II contains the elements of I plus an additional methylenic group. The mass spectrum is also characterized by the primary expulsion of car bon monoxide. Further loss of m/z 15 (C H 3) followed by the elimi nation of H O O C C H 3 yields the base peak m/z 137. The stability of this fragment must be due to the complete conjugated system after the loss of the two side chains. The 'H-NMR showed two additional doublets (2 H) at 8 = 1.4 and 2.3 ppm with a coupl ing constant of / gem = 4.8 Hz; the corresponding signals in the UC-NMR spectrum appeared at Ö = 27.5 ppm. 'H-NMR and 13C-NMR data are given in Table II. The spectroscopic data point to the presence of a cyclopropane ring in II which is absent in I. The large difference between the chemical shifts of the cyclo propane protons either could be due to the aniso- tropic efficiency on the syn-located proton exerted by the double bond or to the influence of the lactone ring [9] . Because of the high field shift of the methyl group to 8 = 1.6 ppm ('H-NMR) and 13.5 ppm (13C-N M R) respectively, the cyclopropane ring should be attached to the C 3 and C 4 atoms. This is also estab lished by the further splitting of the methylene sig nals to a quartet with the long range coupling con stant of 4 Hz in the decoupled I3C-NMR spectrum. It also explains the high -field shift values of 33 and 34 ppm for the quarternary carbon atoms in 3 and 4 in comparison to those of compound I. The mass spectrum of the deuterium labeled-compound II (see Fig. 1 ) showed an increase of the molecular weight of eight mass units and not, as ex pected for two carboxylic acid groups, of 6 mass units. Since diazomethane was used for the methylation of the carboxylic acids the possibility arose that cyclopropanation occurred by the reaction of the methylating reagent with the 2-H-pyran-2-one derivative I.
It could be shown, that treatment of I with diazomethane followed by destination at 150 °C under reduced pressure in the presence of catalytic amounts of copper yielded nearly quantitatively compound II. Cyclopropanation occurred with regioselectivity, the 5,6 double bond was not attacked.
This result finally proved the structure of II.
The success of the cyclopropanation is in disagree ment with earlier investigations on the reaction of diazomethane with pyranone derivatives. Treatment of 2-H-pyran-2-one-5-carboxylic acid chloride, even more reactive than the corresponding ester, with diazomethane only resulted in methylation in the 6-position [7] . According to [7] , the presence of an electronegative substituent in a-position should be a necessary condition for the mentioned reaction. But the reference a-pyrones III-IV containing two car boxylic acid ester groups as well (see Materials and Methods) didn't undergo cyclopropanation even under stronger conditions, e.g. adding diazomethane at room temperature and heating the compound to 200 °C.
Biological activity
The germination inhibitory activity of I in the Amaranthus seed germination test is presented in Table III . methylene-y lactones with plant growth activity it is known, that the activity is enhanced a great deal if the methylenic double bond is replaced by a cyclo propane ring [8] . In case of the compounds discussed here, the increased inhibitory activity of II must be due to the cyclopropanation of the 2-H-pyran-2-one derivate I. While considering possible structural requirements for inhibitory activity, we noticed an interesting rela tionship of II and threo dihydrohematinic acid (VII) which had been detected as germination inhibitor in oat [3] . Opening of the lactone ring of II leads to the tricaboxyl acid derivative VI which has a similar spa tial structure as a certain conformation of VII. This conformation is certainly unfavored because of par tial steric hindrance; it could however exist at a bind ing site of an enzyme or a receptor. The question whether the closed form of II or rather the open form VI acts as the proper germination inhibitor has still to be investigated.
